^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    KA2507

    i
    Other names: KA 2507, KA2507
    Associations
    News
    Trials
    Company:
    Karus Therap, UT MD Anderson Cancer Center
    Drug class:
    HDAC6 inhibitor
    Related drugs:
    Associations
    News
    Trials